Literature DB >> 17897308

Unbalanced protein S deficiency due to warfarin treatment as a possible cause for thrombosis.

Michal Z Haran1, Inna Lichman, Alain Berebbi, Eran Weinmann, Nurit Rosenberg.   

Abstract

The prothrombin time/International Normalized Ratio is an accurate parameter for following most warfarin-treated patients. However, it reflects mostly factor VII levels, and significant disproportionate alterations in other vitamin K-dependent factors may not be reflected properly. We report a rare case of a woman who developed arterial thrombosis whilst receiving therapeutic doses of warfarin, and was found to have a significant and unbalanced protein S deficiency. Discontinuation of warfarin resulted in complete normalization of coagulation factors, and no further thrombotic events under treatment with enoxaparin, with a follow-up of 2.5 years.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17897308     DOI: 10.1111/j.1365-2141.2007.06784.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Quantitative Systems Pharmacology Model to Predict the Effects of Commonly Used Anticoagulants on the Human Coagulation Network.

Authors:  S Hartmann; K Biliouris; L J Lesko; U Nowak-Göttl; M N Trame
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-09-20

2.  A case of aseptic bilateral cavernous sinus thrombosis following a recent inactivated SARS-CoV-2 vaccination.

Authors:  Syntia Nusanti; Ikhwanuliman Putera; M Sidik; Lukman Edwar; Sukamto Koesnoe; Andhika Rachman; Mohammad Kurniawan; Tri Juli Edi Tarigan; Reyhan Eddy Yunus; Indah Saraswati; Siti Halida Zoraida Soraya; Tiara Grevillea Pratomo; Rina La Distia Nora
Journal:  Taiwan J Ophthalmol       Date:  2022-06-15

3.  Rivaroxaban Treatment for Warfarin-Refractory Thrombosis in a Patient with Hereditary Protein S Deficiency.

Authors:  Koken Ameku; Mariko Higa
Journal:  Case Rep Hematol       Date:  2018-01-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.